Carcinoma, Basal Cell
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.
|
24403052 |
2014 |
Estradiol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation.
|
22829776 |
2012 |
High density lipoprotein measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
Serum HDL cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
Estradiol level result
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation.
|
22829776 |
2012 |
Li-Fraumeni Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care.
|
26786923 |
2016 |
Li-Fraumeni Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.
|
21779514 |
2011 |
Li-Fraumeni Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.
|
21343334 |
2011 |
Li-Fraumeni Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.
|
26534844 |
2016 |
Li-Fraumeni Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
|
28418444 |
2017 |
Li-Fraumeni Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
|
28649662 |
2017 |
Li-Fraumeni Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
Mouse models of p53 functions.
|
20452944 |
2010 |
Li-Fraumeni Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
The tumor suppressor gene p53 has an apparent role in breast tumor development in humans, as approximately 30% of sporadic tumors acquire p53 mutations and Li-Fraumeni syndrome patients carrying germ line p53 mutations frequently develop breast tumors at early age.
|
16166291 |
2005 |
Malignant neoplasm of breast
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Malignant neoplasm of breast
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Osteosarcoma
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Osteosarcoma
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Li-Fraumeni Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetic predisposition to hematologic malignancies: management and surveillance.
|
28600339 |
2017 |
Li-Fraumeni Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
|
23788249 |
2013 |
Li-Fraumeni Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Li-Fraumeni Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
Li-Fraumeni Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.
|
28338660 |
2017 |
Sarcoma
|
1.000 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.
|
28338660 |
2017 |
Liver carcinoma
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Liver carcinoma
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|